Hims & Hers Health Hits Day High with 11.62% Surge in Stock Price

Hims & Hers Health, Inc. has experienced significant activity today, with the stock reaching an intraday high of USD 56.31, reflecting a notable gain of 11.62% on September 18, 2025. This small-cap company, operating within the Pharmaceuticals & Biotechnology sector, has demonstrated impressive performance metrics over various time frames.
In the past year, Hims & Hers has achieved a remarkable return of 159.94%, significantly outpacing the S&P 500's 17.14% during the same period. Year-to-date, the stock has surged by 132.42%, further illustrating its strong market position. The company has consistently reported positive results, with a net profit growth of 219.66% as of June 25, and has maintained positive results for 13 consecutive quarters.

Hims & Hers boasts a high institutional ownership rate of 94.57%, indicating strong confidence from institutional investors. Key financial indicators include a return on equity of 36.41% and an operating cash flow of USD 258.59 million, underscoring the company's robust financial health. Overall, Hims & Hers Health, Inc. continues to demonstrate strong performance and resilience in the market.